Anastasia Zherlitsyna — timeline

Metastatic GIST (initially diagnosed as uterine leiomyosarcoma), Kyiv, Ukraine · records 2022–2026 · updated 14 Oct 2026

← all reports

Oncologist protocol — pazopanib approved

Date: 2023-01-04   Institution: Innovacia clinic, Kyiv   Type: Oncology consultation
Source file (Google Drive, docs_eng/): protocol_Jan_2023.docx

Ministry of health of Ukraine
Medical clinic “Innovation” LLC
07352, Ukraine, Kyiv region, Vyshhorods’kyi district, Lyutizh, Vitryanoho Street
Code for the Unified State Register of Enterprises and Organizations of Ukraine 36076865

MEDICAL DOCUMENTATION
Form of primary accounting
documentation No. 028/0
APPROVED
Order of the Ministry of Health
of Ukraine of February 14, 2012
No. 110

Advisory opinion of an oncologist

  1. The name of the health care facility that referred the patient for consultation

  2. Patient's name:
    Zherlitsyna Anastasia Stanislavivna

  3. Date of birth: 25.04.1976 .

  4. Specialty, last name, first name of the consulting physician:
    Oncologist Oksana Mykolaivna Latsinnikova

  5. Results of laboratory study:

  6. Results of functional, X-ray and other special studies:

  7. Specialist's conclusion (established diagnosis):

Main: Uterine leiomyosarcoma T2NxM1 (liver, peritoneum). Condition after 4 cycles of chemotherapy according to the protocol Gemcitabine + Docetaxel + Avastin with progression in the liver (CT scan 01.12.2022). Kit, MET mutations were detected ( ONCOMINE, 12.2022)

Iron deficiency anemia. D-dimer - 2.85.

  1. Recommendations:


1. Given the presence of Kit mutation, it is recommended to start treatment with Pazopanib at 800 mg/day with control (CT, examination) after 2-3 months.
2. Sorbifer 1 tablet 3 times a day 30 minutes before meals for 2 months, then control general blood analysis.
3. Continue Avelox treatment at 400 mg/day for up to 10 days. (in total)
4. Eliquis 2.5 mg 2 times a day. (continued)
5. Hepavista-detox 1 tab 2 times a day.

January 4, 2023

Doctor consultant _______________________________

/Latsinnikova Oksana Mykolayivna/

Head of polyclinic or inpatient department _______________________________